AVC
LOE Approachingsulfanilamide
NDAVAGINALCREAM
Approved
Jun 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5
Data completeness
2/8 — Basic
Drug data last refreshed 5d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AVC is a vaginal cream formulation of sulfanilamide, a sulfonamide antibiotic approved in 1965 for topical vaginal use. It is indicated for bacterial vaginal infections and related conditions. The drug works by inhibiting bacterial folate synthesis, making it bacteriostatic against susceptible organisms.
LOE Approaching
With LOE approaching and limited commercial data available, this product likely operates with a small, stable team focused on maintaining market presence rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (5)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Started Sep 2024
274 enrolled
Geographic AtrophyMacular Degeneration
A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Started Mar 2023
305 enrolled
Geographic Atrophy
AAVCAGsCD59 for the Treatment of Wet AMD
Started Sep 2018
25 enrolled
Wet Age-related Macular Degeneration
Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59
Started Mar 2017
17 enrolled
Dry Age-related Macular Degeneration
Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia
Started Feb 2016
9,845 enrolled
Malaria
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.